Skip to main content

DOT Status and Development in China

  • Chapter
  • First Online:
Handbook of Global Tuberculosis Control
  • 890 Accesses

Abstract

Patient compliance with treatment regimens remains a serious problem in the treatment of tuberculosis (TB) patients. In the decades after the advent of anti-TB drugs in the late 1940s, Directly Observed Therapy (DOT) gradually became a widely accepted and recommended staple of TB treatment management, resulting in the evolution of DOT-based systems worldwide that attempt to ensure patient compliance with their treatment schedules. Most of these DOT programs involve selecting and training supervisors to monitor, record, and enforce patient treatment regimens. Although widely used, DOT programs face many challenges today, especially in low-resource areas such as rural China. In response to these problems, current developments in treatment management involve utilizing new technology and research to discover more effective and efficient ways of ensuring that patients take their medication.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bastian, I., Stapledon, R., & Colebunders, R. (2003). Current thinking on the management of tuberculosis. Current Opinion in Pulmonary Medicine, 9(3), 186–192.

    Article  PubMed  Google Scholar 

  • Cai, J., & Chen, X. (2003). The principle in tuberculosis control in China. Beijing: People’s Public Health Publishing House.

    Google Scholar 

  • Chen, J., Hu, D., Wang, Y., Smith, H., Liu, X., & Wang, T. (2006). Qualitative analysis on the impact factors during the implementation of directly observed medication for smear-positive tuberculosis patients. Modern Preventive Medicine, 11, 2024–2026.

    Google Scholar 

  • Cheng, X., & Gong, W. (2004). Analysis on the effect of full medication management supplemented by family supervision in rural areas. Strait Journal of Preventive Medicine, 31(3), 3–4.

    Google Scholar 

  • Claxton, A. J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics, 23(8), 1296–1310.

    Article  CAS  PubMed  Google Scholar 

  • Dai, Y. S., Li, Q., & Duanmu, H. J. (1994). Comparing study on full course management and DOT of PTB patients. Chinese Journal of Tuberculosis and Respiratory Diseases, 17(5), 278–280.

    CAS  PubMed  Google Scholar 

  • Hu, D., Liu, X., Chen, J., Wang, Y., Wang, T., Zheng, W., et al. (2008). Direct observation and adherence to tuberculosis treatment in Chongqing, China: A descriptive study. Health Policy and Planning, 23(1), 43–55.

    Article  PubMed  Google Scholar 

  • Hu, D. Y., Wang, T., Liu, X. Y., Chen, J., Wang, Y., Zheng, W., et al. (2006). Facts on the performance of directly observed medication in smear-positive tuberculosis patients in Chongqing and the impact factors. China Health Resources, 9(5), 219–221.

    Google Scholar 

  • Khan, M. A., Walley, J. D., Witter, S. N., Imran, A., & Safdar, N. (2002). Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Health Policy and Planning, 17(2), 178–186.

    Article  CAS  PubMed  Google Scholar 

  • Li, S. S., Xu, R. X., & Xiao, C. Z. (1965). Preliminary analysis on the chemotherapy of newly diagnosed smear positive patients. Chinese Journal of Antituberculosis, 6(4), 220–223.

    Google Scholar 

  • Lienhardt, C., & Ogden, J. A. (2004). Tuberculosis control in resource poor countries: Have we reached the limits of the universal paradigm? Tropical Medicine and International Health, 9(7), 833–841.

    Article  PubMed  Google Scholar 

  • Menzies, D., Dion, M. J., Francis, D., Parisien, I., Rocher, I., Mannix, S., et al. (2005). In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection. International Journal of Tuberculosis and Lung Disease, 9(12), 1343–1348.

    CAS  PubMed  Google Scholar 

  • Ministry of Health of The People’s Republic of China. (1992). National TB epidemiological survey in 1990. Beijing: Ministry of Health.

    Google Scholar 

  • Ministry of Health, Disease Control Division. (2002). China tuberculosis control implementation guide. Beijing: Ministry of Health.

    Google Scholar 

  • Ministry of Health, Disease Control Division, Ministry of Health Foreign Loan Office, & Chinese Center for Disease Control and Prevention. (2005). Report on the social assessment of the China Tuberculosis Control Project. Beijing: Ministry of Health.

    Google Scholar 

  • Ministry of Health, Disease Control Division, Ministry of Health, Medical Administration Division, & Chinese Center for Disease Control and Prevention. (2009). Guide for the implementation of tuberculosis control in China. Beijing: China Union University Publishing House.

    Google Scholar 

  • Moulding, T. S., & Caymittes, M. (2002). Managing medication compliance of tuberculosis patients in Haiti with medication monitors. International Journal of Tuberculosis and Lung Disease, 6(4), 313–319.

    CAS  PubMed  Google Scholar 

  • Moulding, T. S., Onstad, G. D., & Sbarbaro, J. A. (1970). Supervision of outpatient drug therapy with the medication monitor. Annals of Internal Medicine, 73(4), 559–564.

    Article  CAS  PubMed  Google Scholar 

  • Paramasivan, R., Parthasarathy, R. T., & Rajasekaran, S. (1993). Short course chemotherapy: A controlled study of indirect defaulter retrieval method. Indian Journal of Tuberculosis, 40, 185–190.

    Google Scholar 

  • Rusen, I. D., Aït-Khaled, N., Alarcón, E., Billo, N., Bissell, K., Boillot, F., et al. (2007). Cochrane systematic review of directly observed therapy for treating tuberculosis: Good analysis of the wrong outcome. International Journal of Tuberculosis and Lung Disease., 11(2), 120–121.

    CAS  PubMed  Google Scholar 

  • Sonnenberg, P., Ross, M. H., Shearer, S. C., & Murray, J. (1998). The effect of dosage cards on compliance with directly observed therapy in hospital. International Journal of Tuberculosis and Lung Disease, 2(2), 168–171.

    CAS  PubMed  Google Scholar 

  • Sun, Q., Meng, Q., Yip, W., Yin, X., & Li, H. (2008). DOT in rural China: Experience from a case study in Shandong Province, China. International Journal of Tuberculosis and Lung Disease, 12(6), 625–630.

    CAS  PubMed  Google Scholar 

  • Tu, D., Wan, L., & Wang, L. (2013). The theory and practice of modern tuberculosis control. Beijing: Military Medical Science Publishing House.

    Google Scholar 

  • Tuberculosis Coalition for Technical Assistance. (2006). International Standards for Tuberculosis Care (ISTC). The Hague: Tuberculosis Coalition for Technical Assistance.

    Google Scholar 

  • Volmink, J., & Garner, P. (2007). Directly observed therapy for treating tuberculosis. Cochrane Database of Systematic Reviews, (4), CD003343.

    Google Scholar 

  • Volmink, J., Matchaba, P., & Garner, P. (2000). Directly observed therapy and treatment adherence. Lancet, 355(9212), 1345–1350.

    Article  CAS  PubMed  Google Scholar 

  • Wang, L., Liu, J., & Jiang, W. (2004). Prevention and treatment of tuberculosis. Beijing: China Union University Publishing House.

    Google Scholar 

  • WHO. (2006). The Stop TB Strategy. Geneva: World Health Organization.

    Google Scholar 

  • WHO. (2008). Global tuberculosis control: Surveillance, planning, financing. Geneva: World Health Organization.

    Google Scholar 

  • Xiao, D., & Wang, Y. (2008). The mid-term evaluation report on the National Tuberculosis Control Program (2001-2010). Beijing: China Union University Publishing House.

    Google Scholar 

  • Yan, B., & Duanmu, H. (2003). Tuberculosis. Beijing: Beijing Press.

    Google Scholar 

  • Zhang, L. (1997). Best practices for tuberculosis control: Short-course chemotherapy under supervision by medical staff directly. China Public Health, 13(12), 709–710.

    Google Scholar 

  • Zhang, B., & Wang, L. (2010). Epoch-making initiative: World Bank Loan/United Kingdom granted tuberculosis project in China: Progress and achievement. Beijing: China Social Publishing House.

    Google Scholar 

  • Zhang, L. X., Wu, Q. C., Lv, S. M., Liu, C. W., & Sun, F. X. (1980). Preliminary analysis on non-hospitalized TB patient DOT in rural area. The Journal of the Chinese Antituberculosis Association, 1, 13–17.

    Google Scholar 

  • Zheng, Y., Wang, J., Zhou, Y., et al. (2009). The survey and analysis of treatment adherence for the smear positive pulmonary tuberculosis patients in Jiangsu province. The Bulletin of Nanjing Medical University, 29(10), 1384.

    Google Scholar 

  • Zhong, Q., & Tang, D. (2013). The minute book of anti-tuberculosis in new China. Guangzhou: Guangdong People’s Publishing House.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shiwen Jiang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Jiang, S., Hu, D., Liu, X. (2017). DOT Status and Development in China. In: Lu, Y., Wang, L., Duanmu, H., Chanyasulkit, C., Strong, A., Zhang, H. (eds) Handbook of Global Tuberculosis Control. Springer, Boston, MA. https://doi.org/10.1007/978-1-4939-6667-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6667-7_9

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4939-6665-3

  • Online ISBN: 978-1-4939-6667-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics